neuro-inflammation program (Longevity Biotech)

N/A

Report date: 2025/03/20 15:09:18
NME

Base Information

Drug Nameneuro-inflammation program (Longevity Biotech)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeuritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLongevity Biotech
China Registration ClassN/A

Develop Information

Active CompaniesLongevity Biotech
Inactive CompaniesN/A
Active IndicationsNeuritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A